Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Immunology 13 (2022): 957874.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
-
Gehlert, Carina Lynn
Rahmati, Pegah
Boje, Ammelie Svea
Winterberg, Dorothee
Krohn, Steffen
Theocharis, Thomas
Cappuzzello, Elisa
Lux, Anja
Nimmerjahn, Falk
Ludwig, Ralf
Lustig, Marta
Rösner, Thies
Valerius, Thomas
Schewe, Denis Martin
Kellner, Christian
Klausz, Katja
Peipp, Matthias
- DOI
-
10.3389/fimmu.2022.957874
- URN
-
urn:nbn:de:bvb:29-opus4-203561
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gehlert, Carina Lynn
- Rahmati, Pegah
- Boje, Ammelie Svea
- Winterberg, Dorothee
- Krohn, Steffen
- Theocharis, Thomas
- Cappuzzello, Elisa
- Lux, Anja
- Nimmerjahn, Falk
- Ludwig, Ralf
- Lustig, Marta
- Rösner, Thies
- Valerius, Thomas
- Schewe, Denis Martin
- Kellner, Christian
- Klausz, Katja
- Peipp, Matthias
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Funktionelle Charakterisierung Fc-optimierter CD19-gerichteter Antikörper
A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
Charakterisierung eines Fc-optimierten CD19-Antikörpers zur Immuntherapie der BCP-ALL
Vector induced skewing of antibody Fc-effector functions
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
Onkogene Effekte von CD19: Vergleichende Untersuchungen an CD19-Verlustvarianten im murinen Burkitt Lymphom
A multi-Fc-species system for recombinant antibody production
IgG Fc engineering to modulate antibody effector functions
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Charakterisierung von Plasmazellsubpopulationen im humanen Knochenmark : Vergleich von CD19-exprimierenden und CD19-nicht exprimierenden Plasmazellen
Funktionelle Charakterisierung Fc-optimierter CD19-gerichteter Antikörper
A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
Charakterisierung eines Fc-optimierten CD19-Antikörpers zur Immuntherapie der BCP-ALL
Vector induced skewing of antibody Fc-effector functions
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
Onkogene Effekte von CD19: Vergleichende Untersuchungen an CD19-Verlustvarianten im murinen Burkitt Lymphom
A multi-Fc-species system for recombinant antibody production
IgG Fc engineering to modulate antibody effector functions
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
Charakterisierung von Plasmazellsubpopulationen im humanen Knochenmark : Vergleich von CD19-exprimierenden und CD19-nicht exprimierenden Plasmazellen
Funktionelle Charakterisierung Fc-optimierter CD19-gerichteter Antikörper
A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
Charakterisierung eines Fc-optimierten CD19-Antikörpers zur Immuntherapie der BCP-ALL
Vector induced skewing of antibody Fc-effector functions
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
Onkogene Effekte von CD19: Vergleichende Untersuchungen an CD19-Verlustvarianten im murinen Burkitt Lymphom
A multi-Fc-species system for recombinant antibody production
IgG Fc engineering to modulate antibody effector functions
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia